Association between serum uric acid and kidney disease with pediatric focus

키워드

참고문헌 (40)

1. Ames BN, "Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer : a hypothesis", Proc Natl Acad Sci U S A, 78, pp.6858~6862 (1981)
2. Alvarez-Lario B, "Uric acid and evolution", Rheumatology(Oxford), 49, pp.2010~2015 (2010)
3. Roman YM, "The role of uric acid in human health : insights from the Uricase gene", J Pers Med, 13, pp.1409~ (2023)
4. Zhu Y, "Prevalence of gout and hyperuricemia in the US general population : the National Health and Nutrition Examination Survey 2007-2008", Arthritis Rheum, 63, pp.3136~3141 (2011)
5. Fishberg AM, "The interpretation of increased blood uric acid in hypertension", Arch Intern Med, 34, pp.503~507 (1924)
6. Chen-Xu M, "Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends : the National Health and Nutrition Examination Survey, 2007-2016", Arthritis Rheumatol, 71, pp.991~999 (2019)
7. Copur S, "Uric acid in metabolic syndrome : does uric acid have a definitive role?", Eur J Intern Med, 103, pp.4~12 (2022)
8. Bardin T, "Definition of hyperuricemia and gouty conditions", Curr Opin Rheumatol, 26, pp.186~191 (2014)
9. Chen JH, "Gender-specific risk factors for incident gout : a prospective cohort study", Clin Rheumatol, 31, pp.239~245 (2012)
10. Cho MH, "Serum uric acid in Korean children and adolescents : reference percentiles and association with metabolic syndrome", Ann Pediatr Endocrinol Metab, 25, pp.104~111 (2020)
11. Kumar J, "Prevalence and causes of hyperuricemia in children", Cureus, 13, pp.e15307~ (2021)
12. Kliegman R, "Nelson textbook of pediatrics" (2019), Elsevier
13. Su HY, "Research advances in the mechanisms of hyperuricemia-induced renal injury", Biomed Res Int, 2020, pp.5817348~ (2020)
14. Ahmad MI, "Urate crystals; beyond joints", Front Med(Lausanne), 8, pp.649505~ (2021)
15. Yang L, "The role of oxidative stress-mediated apoptosis in the pathogenesis of uric acid nephropathy", Ren Fail, 41, pp.616~622 (2019)
16. Sanchez-Lozada LG, "Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats", Kidney Int, 67, pp.237~247 (2005)
17. Domrongkitchaiporn S, "Risk factors for development of decreased kidney function in a southeast Asian population : a 12-year cohort study", J Am Soc Nephrol, 16, pp.791~799 (2005)
18. Weiner DE, "Uric acid and incident kidney disease in the community", J Am Soc Nephrol, 19, pp.1204~1211 (2008)
19. Ben-Dov IZ, "Serum uric acid is a GFR-independent longterm predictor of acute and chronic renal insufficiency : the Jerusalem Lipid Research Clinic cohort study", Nephrol Dial Transplant, 26, pp.2558~2566 (2011)
20. Hsu CY, "Risk factors for end-stage renal disease : 25-year follow-up", Arch Intern Med, 169, pp.342~350 (2009)
21. Rodenbach KE, "Hyperuricemia and progression of CKD in children and adolescents : the chronic kidney disease in children(CKiD)cohort study", Am J Kidney Dis, 66, pp.984~992 (2015)
22. Schwartz GJ, "Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents", Pediatr Nephrol, 38, pp.489~497 (2023)
23. Kang DH, "A role for uric acid in the progression of renal disease", J Am Soc Nephrol, 13, pp.2888~2897 (2002)
24. Kojima S, "Febuxostat for cerebral and cardiorenovascular events prevention study", Eur Heart J, 40, pp.1778~1786 (2019)
25. Ghane Sharbaf F, "Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease", Pediatr Nephrol, 33, pp.1405~1409 (2018)
26. Liu P, "Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia : 3-year randomized parallel-controlled study", Clin Endocrinol(Oxf), 83, pp.475~482 (2015)
27. Doria A, "Serum urate lowering with allopurinol and kidney function in type 1diabetes", N Engl J Med, 382, pp.2493~2503 (2020)
28. Badve SV, "Effects of allopurinol on the progression of chronic kidney disease", N Engl J Med, 382, pp.2504~2513 (2020)
29. Leoncini G, "Uric acid lowering for slowing CKD progression after the CKD-FIX trial : a solved question or still a dilemma?", Clin Kidney J, 15, pp.1666~1674 (2022)
30. Kimura K, "Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia : a randomized trial", Am J Kidney Dis, 72, pp.798~810 (2018)
31. Kataoka H, "Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study", Sci Rep, 12, pp.3784~ (2022)
32. Lima WG, "Uric acid as a modulator of glucose and lipid metabolism", Biochimie, 116, pp.17~23 (2015)
33. Nguyen S, "Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents", J Pediatr, 154, pp.807~813 (2009)
34. Malik VS, "Intake of sugar-sweetened beverages and weight gain : a systematic review", Am J Clin Nutr, 84, pp.274~288 (2006)
35. Kazancioglu R, "Risk factors for chronic kidney disease : an update", Kidney Int Suppl(2011), 3, pp.368~371 (2013)
36. Kidney Disease : Improving Global Outcomes(KDIGO)CKD Work Group, "KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease", Kidney Int, 105(4S), pp.S117~314 (2024)
37. FitzGerald JD, "2020 American College of Rheumatology Guideline for the management of gout", Arthritis Rheumatol, 72, pp.879~895 (2020)
38. Hisatome I, "Japanese Society of Gout and Uric & Nucleic Acids 2019 guidelines for management of hyperuricemia and gout 3rd edition", Gout Uric Nucleic Acids, 44(Suppl), pp.sp-1-40.~ (2020)
39. Lee JJ, "Korean guidelines for the management of gout", Korean J Intern Med, 38, pp.641~650 (2023)
40. Feig DI, "The role of uric acid in the pathogenesis of hypertension in the young", J Clin Hypertens(Greenwich), 14, pp.346~352 (2012)

관련 논문AI추천